drugset / Trial / NCT01717066

the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma

NCT01717066 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

Using the subject with hepatocellular carcinoma in the conventional therapy to evaluate the efficacy and safety of ginsenoside Rg3 (20mg BID) and placebo in prevention and treatment of postoperative recurrence of liver cancer,respectively

Timeline

Start
2012-04
Primary completion
2014-12
Completion
2015-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginsenoside Rg3 Unknown 20 mg —